High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 32, Issue 4, 2003, Pages 197-204

  Suzuki, K ^a   Sawada, Tetsuji ^a   Murakami, A ^b   Matsui, T ^c   Tohma, S ^c   Nakazono, K ^d   Takemura, M ^e   Takasaki, Y ^f   Mimori, T ^g   Yamamoto, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Medical & Biological Laboratories Co Ltd   (Japan)

^c SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^d Niigata Prefectural Senami Hospital   (Japan)

^e GIFU UNIVERSITY   (Japan)

^f JUNTENDO UNIVERSITY   (Japan)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

Anti cyclic citrullinated peptide antibody; Antifilaggrin antibody; Area under the curve; Matrix metalloproteinase 3; Receiver operating characteristic curve; Rheumatoid factor; Sensitivity; Specificity

Indexed keywords

ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FILAGGRIN; FILAGGRIN ANTIBODY; PROTEIN ARGININE DEIMINASE; RECOMBINANT ANTIGEN; RHEUMATOID FACTOR; STROMELYSIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; AREA UNDER THE CURVE; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CITRULLINE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PEPTIDES, CYCLIC; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHEUMATOID FACTOR; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 10744230947     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740310003677     Document Type: Article

References (31)

1. Nienhuis RLF, Mandema E, Smids C. A new serum factor in patients with rheumatoid arthritis, the antiperinuclear factor. Ann Rheum Dis 1964;23:302-5.
2. Young BJJ, Mallya RK, Leslie RD, Clark CJM, Hamblin TJ. Anti-keratin antibodies in rheumatoid arthritis. Br Med J 1979;2:97-9.
3. Girbal E, Sebbag M, Gomès-Daudrix V, Simon M, Vincent C, Serre G. Characterisation of the rat oesophagus epithelium antigens defined by the so-called 'antikeratin antibodies', specific for rheumatoid arthritis. Ann Rheum Dis 1993;52:749-57.
4. Simon M, Girbal E, Sebbag M, Gomès-Daudrix V, Vincent C, Salama G, et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called 'antikeratin antibodies', autoantibodies specific for rheumatoid arthritis. J Clin Invest 1993;92:1387-93.
5. Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux J-J, et al. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995;95:2672-9.
6. Vincent C, Simon M, Sebbag M, Girbal-Neuhauser E, Durieux J-J, Cantagrel A, et al. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol 1998;25:838-46.
7. Vincent C, de Keyser F, Masson-Bessière C, Sebbag M, Veys EM, Serre G. Anti-perinuclear factor compared with the so called 'antikeratin' antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis 1999;58:42-8.
8. Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, et al. Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol 1998;115:294-302.
9. Aho K, Palosuo T, Lukka M, Kurki P, Isomäki H, Kautiainen H, et al. Antifilaggrin antibodies in recent-onset arthritis. Scand J Rheumatol 1999;28:113-6.
10. Masson-Bessière C, Sebbag M, Durieux J-J, Nogueira L, Vincent C, Girbal-Neuhauser E, et al. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000;119:544-52.
11. Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
12. Girbal-Neuhauser E, Durieux J-J, Arnaud M, Dalbon P, Sebbag M, Vincent C, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999;162:585-94.
13. Schellekens GA, Visser H, de Jong BAW, van den Hoogen FHJ, Hazes JMW, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63.
14. Nogueira L, Sebbag M, Vincent C, Arnaud M, Fournié B, Cantagrel A, et al. Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis 2001;60:882-7.
15. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236-43.
16. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001;47:1089-93.
17. Bas S, Perneger TV, Seitz M, Tiercy J-M, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and 1gM rheumatoid factors. Rheumatology (Oxford) 2002;41:809-14.
18. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002;29:2074-6.
19. Vincent C, Nogueira L, Sebbag M, Chapuy-Regaud S, Arnaud M, Letourneur O, et al. Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum 2002;46:2051-8.
20. Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995;38:969-75.
21. Manicourt DH, Fujimoto N, Obata K, Thonar EJ-MA. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation. Arthritis Rheum 1995;38:1031-9.
22. Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, et al. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 1999;26:251-8.
23. So A, Chamot AM, Péclat V, Gerster J-C. Serum MMP-3 in rheumatoid arthritis: correlation with systemic inflammation but not with erosive status. Rheumatology (Oxford) 1999;38:407-10.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Kanno T, Kawada A, Yamanouchi J, Yosida-Noro C, Yoshiki A, Shiraiwa M, et al. Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. J Invest Dermatol 2000;115:813-23.
26. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
27. Vossenaar ER, van Venrooij WJ, Pruijn GJM. Anti-CCP antibodies in (early) rheumatoid arthritis. In: Conrad K, Fritzler M, Meurer M, Sack U, Shoenfeld Y, eds. Proteomics to molecular epidemiology: relevance of autoantibodies. Lengerich: Pabst Science Publishers, 2002:454-62.
28. Zucker S, Mian N, Drews M, Conner C, Davidson A, Miller F, et al. Increased serum stromelysin-1 levels in systemic lupus erythematosus: lack of correlation with disease activity. J Rheumatol 1999;26:78-80.
29. Reparon-Schuijt CC, van Esch WJE, van Kooten C, Schellekens GA, de Jong BAW, van Venrooij WJ, et al. Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 2001;44:41-7.
30. Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001;166:4177-84.
31. Lapointe E, Déry U, Vaillancourt F, Ménard HA, Senshu T. Rheumatoid sera potentially recognize all citrullinated proteins. Arthritis Rheum 1999;42 Suppl:S86.